Abstract: An ophthalmic system for generating an ocular model of an eye includes an optical coherence tomography (OCT) device, an aberrometer, and a computer. The OCT device detects OCT light reflected from the eye. The aberrometer detects aberrometer light reflected from the eye. The computer generates the ocular model of the eye according to the reflected OCT light. The ocular model includes parameters describing the eye. The parameters include lens parameters that describe the lens of the eye. The computer determines an OCT-based wavefront according to the ocular model, determines an aberrometer-based wavefront according to the reflected aberrometer light, and compares the OCT-based and the aberrometer-based wavefronts. If the wavefronts differ beyond a predefined tolerance, the computer adjusts one or more values assigned to the parameters until the wavefronts satisfy the predefined tolerance. At least one adjusted value is assigned to a lens parameter.

Abstract: Methods, computing devices, and software programs for identifying a driving scenario in real-time driving data. A driving scenario is received and translated into an ordered sequence of events that correspond to the driving scenario. A signal computation function is determined for each event in the sequence, which quantifies proximity to the respective event. Driving data is received for a plurality of time steps. Values of each signal computation function are determined, evaluated for the driving data at each of the plurality of time steps. It is determined whether the driving scenario has occurred in the driving data based on the values of the signal computation function. A first portion of the driving data is either modified, discarded, or stored in memory based on the determination whether the driving scenario has occurred.

Abstract: A pharmacotherapeutic protocol enhancing neuro-restoration in the human brain for patients suffering with brain injuries and diseases, wherein the protocol comprises treating the patient with a combinatorial pharmacological composition comprising a pharmacologically effective amount of a first Neuroplasticity PA therapeutic agent exhibiting a mechanism of plasticity in at least one of Neurogenesis, Synaptogenesis, Remyelination, Angiogenesis, Bioenergetics, Inflammation and Apoptosis, and a pharmacologically effective amount of a second Neuroplasticity PA therapeutic agent exhibiting a mechanism of plasticity in at least one of Neurogenesis, Synaptogenesis, Remyelination, Angiogenesis, Bioenergetics, Inflammation and Apoptosis; wherein the mechanism of plasticity of the first Neuroplasticity PA therapeutic agent differs from the mechanism of plasticity of the second Neuroplasticity PA therapeutic agent. Combinatorial pharmacological composition are also disclosed.

Abstract: The present disclosure relates to systems, methods, and computer-readable media for securely verifying an identity of a user of a client device based on a signal transmitted by the client device. For example, systems disclosed herein include registering a client device and facility device via a cloud computing system to enable the client device and facility device to securely communicate a signal via a wireless connection. The systems disclosed herein additionally include determining whether a trigger condition applies based on a position of the client device relative to the facility device. The systems disclosed herein further include maintaining and updating a subset of user verification information to include personal verification of a registered user of the client device. Using the subset of user verification information, a biometric scanning device may efficiently and accurately verify an identity of an individual associated with the client device.

Abstract: The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A).

Abstract: In some examples, an electronic device includes a network interface to connect to a computer network, a display port operating as a display input, an input/output port, memory having a plurality of profiles, and a processor coupled to the memory. In some examples, the processor is to change an operation of the input/output port based on a profile of the plurality of profiles. In some examples, the processor is to change the display port from the display input to a display output based on the profile of the plurality of profiles.

Abstract: A device may receive a first user interaction signal in response to a first user interaction with a first user interaction element. In response to the first user interaction signal, the device may provide a first instruction to the computing system to perform a first action with respect to the first indicator, wherein the first indicator is active. The device may receive a switch control signal in response to a second user interaction with a switch control element. The device may set the first indicator as the inactive indicator and the second indicator as the active indicator. The device may receive a second user interaction signal in response to a third user interaction with the first user interaction element and use the second controller to provide a second instruction to the computing system to perform a second action with respect to the second indicator.

Abstract: Techniques are disclosed for utilizing synchronized robot observations. The techniques may include receiving first log data associated with a first vehicle, receiving second log data associated with a second vehicle, determining that a first portion of the first log data is time related to a second portion of the second log data, and using the first portion and the second portion for mapping and/or training models.

Abstract: A memory attribute structure, which is configurable, is used when processing memory access transactions through an execution path of a processing system. The memory attribute structure includes one or more memory address entries. The entries are configurable. Each memory address entry comprising a respective memory address range mapped to a respective priority level of a set of priority levels. A central processing unit is configured to use the memory attribute structure to determine respective priority levels mapped to respective memory addresses of respective memory access transaction, and process the respective memory access transactions based on the respective priority levels.

Abstract: A memory attribute structure comprises one or more memory address entries. Each memory address entry comprising a respective memory address range mapped to a respective priority level. The memory attribute table is used when processing a memory access transaction through an execution path of a processing system. During said processing, a memory address of the memory access transaction is determined. The memory attribute structure is used to determine a priority level mapped to the determined memory address, and the memory access transaction is processed based on the determined priority level.